Shenzhen Original Advanced Compounds Past Earnings Performance
Past criteria checks 0/6
Shenzhen Original Advanced Compounds has been growing earnings at an average annual rate of 9.8%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been declining at an average rate of 19.2% per year.
Key information
9.8%
Earnings growth rate
10.2%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | -19.2% |
| Return on equity | -13.5% |
| Net Margin | -16.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Shenzhen Original Advanced Compounds Co., Ltd.'s (SHSE:603991) 27% Share Price Surge Not Quite Adding Up
Sep 26
There's Reason For Concern Over Shenzhen Original Advanced Compounds Co., Ltd.'s (SHSE:603991) Massive 30% Price Jump
Jun 12Shenzhen Original Advanced Compounds Co., Ltd. (SHSE:603991) Shares May Have Slumped 29% But Getting In Cheap Is Still Unlikely
Apr 21Shenzhen Original Advanced Compounds Co., Ltd.'s (SHSE:603991) 27% Share Price Surge Not Quite Adding Up
Mar 07Revenue & Expenses Breakdown
How Shenzhen Original Advanced Compounds makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 280 | -45 | 51 | 15 |
| 30 Jun 24 | 245 | -41 | 52 | 15 |
| 31 Mar 24 | 249 | -46 | 51 | 16 |
| 31 Dec 23 | 239 | -44 | 47 | 13 |
| 30 Sep 23 | 209 | -21 | 53 | 11 |
| 30 Jun 23 | 181 | -20 | 51 | 8 |
| 31 Mar 23 | 136 | -19 | 46 | 5 |
| 31 Dec 22 | 130 | -17 | 45 | 5 |
| 30 Sep 22 | 98 | -47 | 52 | 6 |
| 30 Jun 22 | 108 | -49 | 52 | 6 |
| 31 Mar 22 | 119 | -52 | 53 | 6 |
| 31 Dec 21 | 128 | -53 | 53 | 7 |
| 30 Sep 21 | 176 | -29 | 23 | 7 |
| 30 Jun 21 | 188 | -33 | 32 | 12 |
| 31 Mar 21 | 274 | -40 | 35 | 15 |
| 31 Dec 20 | 311 | -48 | 41 | 16 |
| 30 Sep 20 | 376 | -84 | 58 | 21 |
| 30 Jun 20 | 423 | -90 | 59 | 24 |
| 31 Mar 20 | 399 | -73 | 65 | 25 |
| 31 Dec 19 | 462 | -57 | 64 | 26 |
| 30 Sep 19 | 504 | 3 | 61 | 22 |
| 30 Jun 19 | 550 | 28 | 57 | 20 |
| 31 Mar 19 | 603 | 31 | 56 | 22 |
| 31 Dec 18 | 570 | 34 | 56 | 22 |
| 30 Sep 18 | 569 | 40 | 49 | 23 |
| 30 Jun 18 | 521 | 37 | 36 | 30 |
| 31 Mar 18 | 458 | 39 | 33 | 22 |
| 31 Dec 17 | 427 | 38 | 35 | 19 |
| 30 Sep 17 | 362 | 38 | 29 | 15 |
| 30 Jun 17 | 345 | 37 | 44 | 0 |
| 31 Mar 17 | 358 | 38 | 47 | 0 |
| 31 Dec 16 | 351 | 37 | 45 | 0 |
| 31 Dec 15 | 301 | 34 | 44 | 0 |
| 31 Dec 14 | 272 | 30 | 39 | 0 |
| 31 Dec 13 | 219 | 21 | 38 | 0 |
Quality Earnings: 603991 is currently unprofitable.
Growing Profit Margin: 603991 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 603991 is unprofitable, but has reduced losses over the past 5 years at a rate of 9.8% per year.
Accelerating Growth: Unable to compare 603991's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 603991 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-5.3%).
Return on Equity
High ROE: 603991 has a negative Return on Equity (-13.53%), as it is currently unprofitable.